M. Meagher Et Al. , "PD18-01 CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS RECEIVING TKI THERAPY VERSUS IMMUNE CHECKPOINT INHIBITOR THERAPY: ANALYSIS OF THE REMARCC REGISTRY," Journal Of Urology , vol.207, no.Supplement 5, pp.342, 2022
Meagher, M. Et Al. 2022. PD18-01 CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS RECEIVING TKI THERAPY VERSUS IMMUNE CHECKPOINT INHIBITOR THERAPY: ANALYSIS OF THE REMARCC REGISTRY. Journal Of Urology , vol.207, no.Supplement 5 , 342.
Meagher, M., Minervini, A., Mir, M., Rebez, G., Autorino, R., Campi, R., ... Kriegmair, M.(2022). PD18-01 CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS RECEIVING TKI THERAPY VERSUS IMMUNE CHECKPOINT INHIBITOR THERAPY: ANALYSIS OF THE REMARCC REGISTRY. Journal Of Urology , vol.207, no.Supplement 5, 342.
Meagher, Margaret Et Al. "PD18-01 CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS RECEIVING TKI THERAPY VERSUS IMMUNE CHECKPOINT INHIBITOR THERAPY: ANALYSIS OF THE REMARCC REGISTRY," Journal Of Urology , vol.207, no.Supplement 5, 342, 2022
Meagher, Margaret Et Al. "PD18-01 CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS RECEIVING TKI THERAPY VERSUS IMMUNE CHECKPOINT INHIBITOR THERAPY: ANALYSIS OF THE REMARCC REGISTRY." Journal Of Urology , vol.207, no.Supplement 5, pp.342, 2022
Meagher, M. Et Al. (2022) . "PD18-01 CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS RECEIVING TKI THERAPY VERSUS IMMUNE CHECKPOINT INHIBITOR THERAPY: ANALYSIS OF THE REMARCC REGISTRY." Journal Of Urology , vol.207, no.Supplement 5, p.342.
@article{article, author={Margaret Meagher Et Al. }, title={PD18-01 CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS RECEIVING TKI THERAPY VERSUS IMMUNE CHECKPOINT INHIBITOR THERAPY: ANALYSIS OF THE REMARCC REGISTRY}, journal={Journal Of Urology}, year=2022, pages={342} }